DeepMed Research

The New York State Psychiatric Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1895-01-01

Employees: 251

Market Cap: -

Website: http://www.nyspi.org

Clinical Trials

Promoting Mother-Baby Bonding Through a Relaxation Routine During Pregnancy

Not Applicable

Completed

Conditions: Psychological Stress in Pregnancy

Interventions: Behavioral: Relaxation Exercise

First Posted Date: 2016-10-24

Last Posted Date: 2023-08-01

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 106

Registration Number: NCT02943083

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder

Phase 1

Completed

Conditions: Cannabis Use Disorder

Interventions: Drug: lorcaserin
Other: Fitbit Charge HR

First Posted Date: 2016-10-13

Last Posted Date: 2019-10-11

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 17

Registration Number: NCT02932215

Locations: 🇺🇸
Columbia Substance Treatment and Research Service, New York, New York, United States

Pomaglumetad Effects on Glutamate Biomarkers

Phase 1

Completed

Conditions: Healthy Controls

Interventions: Drug: POMA
Drug: placebo

First Posted Date: 2016-09-29

Last Posted Date: 2018-09-12

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 95

Registration Number: NCT02919774

Locations: 🇺🇸
University of Alabama, Birmingham, Birmingham, Alabama, United States
🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
🇺🇸
New York University, New York, New York, United States

and more 1 locations

Effect of Clonazepam on Cannabis Withdrawal and Relapse in Treatment-seeking Patients

Phase 2

Completed

Conditions: Cannabis Use Disorder

Interventions: Drug: Placebo
Drug: Clonazepam

First Posted Date: 2016-09-26

Last Posted Date: 2021-08-06

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 68

Registration Number: NCT02913924

Locations: 🇺🇸
Substance Treatment Research Service (STARS) of Columbia University, New York, New York, United States

Cannabinoid Medication for Adults With OCD

Phase 1

Completed

Conditions: Obsessive-Compulsive Disorder

Interventions: Drug: Nabilone
Behavioral: Exposure and Response Prevention Therapy

First Posted Date: 2016-09-22

Last Posted Date: 2020-08-06

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 16

Registration Number: NCT02911324

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Remediation of Auditory Recognition in Schizophrenia With tDCS

Not Applicable

Completed

Conditions: Schizophrenia
Schizoaffective Disorder

Interventions: Device: Sham Transcranial direct current stimulation (tDCS)
Device: Active Transcranial direct current stimulation (tDCS)
Behavioral: Control computer activities
Behavioral: Auditory Remediation

First Posted Date: 2016-08-16

Last Posted Date: 2021-07-08

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 20

Registration Number: NCT02869334

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder

Phase 2

Completed

Conditions: Attention-deficit/Hyperactivity Disorder
Cannabis Use Disorder

Interventions: Drug: Matched placebo
Drug: Adderall-XR

First Posted Date: 2016-06-16

Last Posted Date: 2021-04-09

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 33

Registration Number: NCT02803229

Locations: 🇺🇸
New York Psychiatric Institute, New York, New York, United States

Brief Intervention for OCD Fears

Phase 4

Withdrawn

Conditions: Obsessive-compulsive Disorder

Interventions: Drug: Propanolol
Drug: Placebo

First Posted Date: 2016-06-06

Last Posted Date: 2023-04-18

Lead Sponsor: New York State Psychiatric Institute

Registration Number: NCT02790710

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Brief Intervention to Reduce Fear of Public Speaking

Phase 4

Terminated

Conditions: Social Anxiety Disorder

Interventions: Drug: propranolol
Drug: Placebo

First Posted Date: 2016-06-06

Last Posted Date: 2023-06-07

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 6

Registration Number: NCT02790736

Locations: 🇺🇸
New York State Psychiatric Institute, 1051 Riverside Drive, New York, New York, United States

Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia

Completed

Conditions: Schizophrenia
Schizoaffective Disorder

Interventions: Drug: Mood stabilizer
Drug: Antipsychotic
Drug: Antidepressant
Drug: Benzodiazepine

First Posted Date: 2016-05-18

Last Posted Date: 2024-05-01

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 81921

Registration Number: NCT02775864

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy